Nutra Pharma Corp. filed its 10-K on Feb 05, 2021 for the period ending Dec 31, 2018. In this report its auditor, Rotenberg Meril Solomon Bertiger & Guttilla, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
Mar. 22 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
Mar. 22 | Nutra Pharma Corporation Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 706K | |
+22.88% | 42.68B | |
-2.94% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.88% | 24.94B | |
-19.78% | 18.96B | |
+29.43% | 12.3B | |
-3.19% | 11.95B | |
-2.36% | 11.55B |
- Stock Market
- Equities
- NPHC Stock
- News Nutra Pharma Corp.
- Nutra Pharma Corp. Auditor Raises 'Going Concern' Doubt